We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
11:40 - 12:40
A1 Plenary
Highlights: Joint Green Journal - The Lancet Oncology: Top Clinical Trials
Cheryl Lai, United Kingdom;
Pierre Blanchard, France
Proffered Papers
Interdisciplinary
11:40 - 11:49
Final Results of the TROG 15.03 FASTRACK II Clinical Trial: Stereotactic Ablative Body Radiotherapy (SABR) for Primary Kidney Cancer
Shankar Siva, Australia
-505
11:49 - 11:52
Discussant
Ajay Aggarwal, United Kingdom
11:52 - 12:01
Dose escalation with intraoperative radiotherapy in newly-diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised phase 3 trial
Frank Giordano, Germany
-759
12:01 - 12:04
Discussant
Gerben Borst, United Kingdom
12:04 - 12:13
Clinical and treatment characteristics associated with local control following SBRT: interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohort
Umberto Ricardi, Italy
-2986
12:13 - 12:16
Discussant
Federica Ferrario, Italy
12:16 - 12:25
Internal Mammary and Medial Supraclavicular irradiation in stage I-III breast cancer: 20 years results of the randomised EORTC trial 22922/10925, including in pN0 patients
Philip Poortmans, Belgium
-5580
12:25 - 12:34
When less is not enough: first results from the phase III randomized DBCG RT Natural trial
Birgitte Offersen, Denmark
-5495
12:34 - 12:40
Discussant
Charlotte Coles, United Kingdom